Find a Cancer Provider

Are you a referring physician?
within
I am searching for a
Reset Form
Joshua M. Bauml, MD

Joshua M. Bauml, MD Physician

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Bauml is employed by Penn Medicine.

Clinical Specialties

Specialty:

  • Medical Oncology

Programs & Centers:

Board Certification:

  • Internal Medicine, 2011
  • Medical Oncology, 2014

Clinical Expertise:

  • Adenocarcinoma of Lung
  • Adenocarcinoma of the Head and Neck
  • Adenoid Cystic Carcinoma
  • Anaplastic Cancer of Thyroid
  • Base of Skull Tumors
  • Biological Targeted Therapy
  • Cancer Chemotherapy
  • Cancer of the Hard/Soft Palate
  • Cancer of the Nasal Cavity
  • Cancer of the Parotid
  • Cancer of the Supraglottis
  • Cancer of the Vocal Cords
  • Diaphragm Tumor
  • Ear and Temporal Bone Tumors
  • Esophageal Cancer
  • Follicular Cancer of Thyroid
  • Glottic Cancer
  • Head and Neck Melanoma
  • Head and Neck Sarcoma
  • Head and Neck Tumor
  • Hurthle Cell Cancer
  • Hypopharyngeal Cancer
  • Immunotherapy
  • Jaw Cancer
  • Large Cell Cancer of the Lung
  • Laryngeal Cancer
  • Lung Carcinoid Tumor
  • Medullary Cancer of Thyroid
  • Merkel Cell Carcinoma
  • Mesothelioma
  • Metastatic Squamous Neck Cancer with Occult Primary
  • Mouth Cancer (Oral Cancer)
  • Nasal Cavity and Paranasal Sinus Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Non-Small Cell Lung Cancer
  • Oropharyngeal Cancer
  • Papillary Cancer of Thyroid
  • Parathyroid Cancer
  • Pituitary Cancer
  • Pleural Cancer
  • Salivary Gland Cancer
  • Sarcoma of the Lung
  • Sinus Cancer
  • Small Cell Lung Cancer
  • Squamous Cancer of the Lung
  • Squamous Cell Carcinoma of the Esophagus
  • Squamous Cell Carcinoma of the Head and Neck
  • Squamous Cell Carcinoma of the Mouth
  • Squamous Cell Carcinoma of the Throat
  • Squamous Cell Carcinoma of the Tonsils
  • Temporal Bone Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymoma and Thymic Carcinoma
  • Tongue Cancer
  • Tonsil Cancer
  • Tracheal Cancer
  • Tumor of Parotid Gland
Show All Expertise

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Mount Sinai School of Medicine
Residency: Mount Sinai Medical Center
Fellowship: Hospital of the University of Pennsylvania

Memberships

American Society of Clinical Oncology, National International Association for the Study of Lung Cancer, International International Association for the Study of Lung Cancer, International Lungevity Foundaton, National

Hospital Affiliation

Dr. Bauml is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Chao HC, Schonewolf CA, Tan EX, Swisher-McClure S, Ghiam AF, Weinstein GS, O’Malley BW, Chalian AA, Rassekh CH, Newman JG, Cohen RB, Bauml JM, Aggarwal C, Lin A, Lukens JN: The Impact of Treatment Package Time on Locoregional Control for HPV+ Oropharyngeal Squamous Cell Carcinoma Treated with Surgery and Postoperative (Chemo)Radiation Head and Neck : 2019.

Horn L, Bauml J, Forde PM, Davis KL, Myall NJ, Sasane M, Dalal A, Culver K, Wozniak AJ, Baik CS, Mutebi A, Zhang P, Wakelee HA, Johnson BE: Real- World Treatment Patterns and Survival of Patients with BRAF V600-mutated Metastatic Non-Small Cell Lung Cancer. Lung Cancer : 2019.

Ng TL, Smith DE, Mushtag R, Patil T, Dimou A, Yang S, Liu Q, Li X, Zhou C, Jones RT, Tu MM, Yan F, Bowman IA, Liu SV, Newkirk S, Bauml J, Doebele RC, Aisner DL, Gao D, Ren S, Camidge DR: ROS1 Gene Rearrangements are Associated with an Elevated Risk of Peridiagnosis Thromboembolic Events Journal of Thoracic Oncology : 2019.

Aggarwal C, Thompson JC, Black TA, Katz SI, Fan R, Yee SS, Chien AL, Evans TL, Bauml JM, Alley EW, Ciunci CA, Berman AT, Cohen RB, Lieberman DB, Majmundar KS, Savitch SL, Morrissette JJD, Hwang WT, Elenitoba-Johnson KSJ, Langer CJ, Carpenter EL.: Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer JAMA Oncology : 2019.

Bauml JM, Mick R, Ciunci C, Aggarwal C, Davis C, Evans T, Deshpande C, Miller L, Patel P, Alley E, Knepley C, Mutale F, Cohen RB, Langer CJ: Phase II Trial of Pembrolizumab Following Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer. JAMA Oncology : 2019.

Bange E, Marmarelis ME, Hwang WT, Yang YX, Thompson JC, Rosenbaum J, Bauml JM, Ciunci C, Alley EW, Cohen RB, Langer CJ, Carpenter E, Aggarwal C: Impact of KRAS and TP53 Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients with STK11-Mutated Advanced Non-Small Cell Lung Cancer JCO - Precision Oncology : 2019.

Aggarwal C, Cohen RB, Morrow MP, Kraynyak KA, Sylvester AJ, Knoblock DM, Bauml JM, Weinstein GS, Lin A, Boyer J, Sakata L, Tan S, Anton A, Dickerson K, Mangrolia D, Vang R, Dallas M, Oyola S, Duff S, Esser M, Kumar R, Weiner D, Csiki I, Bagarazzi ML: Immunotherapy Targeting HPV 16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer Clinical Cancer Research : 2019.

Aggarwal C, Haas AR, Metzger S, Aguilar LK, Aguilar-Cordova E, Manzanera AG, Gomez-Hernandez G, Katz SI, Alley EW, Evans TL, Bauml JM, Cohen RB, Langer CJ, Albelda SM, Sterman DH: Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion Molecular Therapy : 2018.

Romero SAD, Jones L, Bauml JM, Li QS, Cohen RB, Mao JJ.: The association between fatigue and pain symptoms and decreased physical activity after cancer Supportive Care in Cancer 32 (17): 2018.

Hammer M, Bagley S, Aggarwal C, Bauml J, Nachiappan AC, Simone CB 2nd, Langer C, Katz SI: Thoracic Imaging of Non-Small Cell Lung Cancer Treated with Anti-programmed Death Receptor-1 Therapy Curr Probl Diagn Radiol : 2018.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
South Pavilion, Floor 10
Office #10-140
3400 Civic Center Blvd

Philadelphia, PA 19104
Phone: (215) 614-1853
Patient appointments: 800-789-7366 (PENN)